Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

antihemophilic factor

antihemophilic factor
  • Formulary
  • Non-formulary
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Advate POWDER FOR INJECTION, INTRAVENOUS recombinant      
Recombinate (obsolete) POWDER FOR INJECTION, INTRAVENOUS recombinant        
Comments:

Recombinate has been discontinued by the manufacturer. Takeda will continue providing Recombinate to patients until the existing supply is exhausted. Inpatients should use their home supply.

Advate is considered non-formulary.

Reviewed: February 28, 2006 (Advate)

Last updated: Jun. 11, 2025






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2025 Rpharmy, LLC ­ All Rights Reserved